• Home
• HAPE Database
• Altitude Sickness
• High Altitude
• Cautionary Tales
• Calculators
• Expeditions

Matthew Bates is a co-founder and secretary of Apex and coordinated the largest drug trial ever conducted at high altitude during the second Apex expedition. He is a Wellcome Trust Clinical Research Fellow and Honorary Specialist Registrar in Cardiology in Newcastle upon Tyne.

Recent publications:

1. Use of Stochastic Multi-Criteria Decision Analysis to Support Sustainable Management of Contaminated Sediments.

Sparrevik M, Barton DN, Bates ME, Linkov I. Environ Sci Technol. 2012 Jan 17.PMID: 22191941

2. Mitochondrial respiratory chain disease in children undergoing cardiac transplantation: A prospective study.

Bates MG, Nesbitt V, Kirk R, He L, Blakely EL, Alston CL, Brodlie M, Hasan A, Taylor RW, McFarland R. Int J Cardiol. 2011 Dec 20.PMID: 22188990

3. A decision-directed approach for prioritizing research into the impact of nanomaterials on the environment and human health.

Linkov I, Bates ME, Canis LJ, Seager TP, Keisler JM. Nat Nanotechnol. 2011 Oct 2;6(12):784-7. doi: 10.1038/nnano.2011.163. PMID: 21963715

4. Sildenafil citrate for the prevention of high altitude hypoxic pulmonary hypertension: double blind, randomized, placebo-controlled trial.

Bates MG, Thompson AA, Baillie JK, Sutherland AI, Irving JB, Hirani N, Webb DJ. High Alt Med Biol. 2011 Fall;12(3):207-14.PMID: 21962063

5. Environmental radiation: risk benchmarks or benchmarking risk assessment.

Bates ME, Valverde LJ Jr, Vogel JT, Linkov I. Integr Environ Assess Manag. 2011 Jul;7(3):400-3. doi: 10.1002/ieam.227. PMID: 21608107

6. Do implantable cardioverter defibrillators improve survival in patients with severe left ventricular systolic dysfunction after coronary artery bypass graft surgery?

Fazal IA, Bates MG, Matthews IG, Turley AJ. Interact Cardiovasc Thorac Surg. 2011 Jun;12(6):1010-6. Epub 2011 Mar 11.PMID: 21398652

7. In patients undergoing aortic valve replacement, what factors predict the requirement for permanent pacemaker implantation?

Matthews IG, Fazal IA, Bates MG, Turley AJ. Interact Cardiovasc Thorac Surg. 2011 Mar;12(3):475-9. Epub 2010 Dec 7.PMID: 21138915

8. Postoperative permanent pacemaker implantation in patients undergoing trans-catheter aortic valve implantation: what is the incidence and are there any predicting factors?

Bates MG, Matthews IG, Fazal IA, Turley AJ. Interact Cardiovasc Thorac Surg. 2011 Feb;12(2):243-53. Epub 2010 Nov 23.PMID: 21098508

9. Large thrombus burden in acute myocardial infarction: successful use of distal protection device following failure of thrombus aspiration.

Bates MG, Matthews IG, Hall JA. Heart. 2010 Sep;96(17):1371.PMID: 20801855

10. The citric acid cough threshold and the ventilatory response to carbon dioxide on ascent to high altitude.

Thompson AA, Baillie JK, Bates MG, Schnopp MF, Simpson A, Partridge RW, Drummond GB, Mason NP. Respir Med. 2009 Aug;103(8):1182-8. Epub 2009 Mar 19.PMID: 19303278

11. Oral antioxidant supplementation does not prevent acute mountain sickness: double blind, randomized placebo-controlled trial.

Baillie JK, Thompson AA, Irving JB, Bates MG, Sutherland AI, Macnee W, Maxwell SR, Webb DJ. QJM. 2009 May;102(5):341-8. Epub 2009 Mar 9.PMID: 19273551

12. Endogenous urate production augments plasma antioxidant capacity in healthy lowland subjects exposed to high altitude.

Baillie JK, Bates MG, Thompson AA, Waring WS, Partridge RW, Schnopp MF, Simpson A, Gulliver-Sloan F, Maxwell SR, Webb DJ. Chest. 2007 May;131(5):1473-8.PMID: 17494796

13. Phosphodiesterase type 5 inhibitors in the treatment and prevention of high altitude pulmonary edema.

Bates MG, Thompson AA, Baillie JK. Curr Opin Investig Drugs. 2007 Mar;8(3):226-31. PMID: 17408118